Literature DB >> 2254771

Prevalence of Raynaud phenomenon in the adult population of South Carolina.

M C Weinrich1, H R Maricq, J E Keil, A R McGregor, F Diat.   

Abstract

A prevalence estimate for Raynaud phenomenon among adult residents of South Carolina was based on data obtained from respondents in a statewide health survey, followed by face-to-face interviews and clinical screening for Raynaud phenomenon, using a screening procedure developed by the authors. The survey obtained 5246 personal interviews from a probability sample of over 3000 households, and 494 survey subjects participated in the clinical screening. The prevalence estimates and their standard errors were computed using survey case weights, design-based estimation, and logistic modelling techniques. The prevalence of Raynaud phenomenon among adult residents of South Carolina was determined to be 3.5%, with a standard error of 0.6%. Prevalence was higher for females (4.3%, SE = 0.7%) than for males (2.7%, SE = 0.6%). These figures are much lower than most estimates in the existing literature on Raynaud phenomenon.

Mesh:

Year:  1990        PMID: 2254771     DOI: 10.1016/0895-4356(90)90101-t

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

2.  The effects of stress, anxiety, and outdoor temperature on the frequency and severity of Raynaud's attacks: the Raynaud's Treatment Study.

Authors:  K M Brown; S J Middaugh; J A Haythornthwaite; L Bielory
Journal:  J Behav Med       Date:  2001-04

3.  Prevalence of Raynaud's phenomenon in a healthy Greek population.

Authors:  P V Voulgari; Y Alamanos; D Papazisi; K Christou; C Papanikolaou; A A Drosos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

4.  [Acral necrosis in metastatic ovarian carcinoma. A single episode of Moschowitz syndrome during gemcitabine chemotherapy].

Authors:  M J Behne; U Hauswirth; A Menz; N Brüllke; U Müllerleile; I Moll
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

5.  Raynaud's phenomenon: prevalence in an Italian population sample.

Authors:  Rossella De Angelis; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

6.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

Review 7.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

8.  A Randomized Controlled Trial of Acupressure for the Treatment of Raynaud's Phenomenon: The difficulty of conducting a trial in Raynaud's phenomenon.

Authors:  Heather Gladue; Veronica Berrocal; Richard Harris; Pei-Suen Tsou; Gautam Edhayan; Ray Ohara; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-05-02

9.  Prevalence of Raynaud's phenomenon in different groups of workers operating hand-held vibrating tools.

Authors:  S M Mirbod; H Yoshida; Y Komura; S Fujita; C Nagata; K Miyashita; R Inaba; H Iwata
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

10.  Diagnosis and risk stratification in patients with anti-RNP autoimmunity.

Authors:  M F Carpintero; L Martinez; I Fernandez; A C Garza Romero; C Mejia; Y J Zang; R W Hoffman; E L Greidinger
Journal:  Lupus       Date:  2015-03-02       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.